New Antibiotic Hits the Market to Tackle Stubborn UTIs

Published on October 29, 2024
E Coli

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs.